These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1114967)
1. Development and management of extrapyramidal symptoms in hypertensive patients treated with diazoxide. Pohl JE Am Heart J; 1975 Mar; 89(3):401-2. PubMed ID: 1114967 [No Abstract] [Full Text] [Related]
2. Development of extrapyramidal symptoms in hypertensive patients treated with diazoxide. Neary D; Thurston H; Pohl JE Br Med J; 1973 Sep; 3(5878):474-5. PubMed ID: 4726153 [TBL] [Abstract][Full Text] [Related]
3. [Letter: Diazoxide and extrapyramidal syndromes]. Simon P; Rambert F Nouv Presse Med; 1974 Mar; 3(10):608. PubMed ID: 4822956 [No Abstract] [Full Text] [Related]
9. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)]. Sigwald J Therapeutique; 1972 Nov; 48(9):561-8. PubMed ID: 4650525 [No Abstract] [Full Text] [Related]
10. Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control. Mindham RH Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):395-400. PubMed ID: 9965 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms. Murphy JE; Stewart RB Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755 [TBL] [Abstract][Full Text] [Related]
12. [Syndrome involving the extrapyramidal motor systems and their drug treatment]. Soyka D Fortschr Med; 1974 Aug; 92(22):906-9. PubMed ID: 4153689 [No Abstract] [Full Text] [Related]
13. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics. Moleman P; Schmitz PJ; Ladee GA J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250 [TBL] [Abstract][Full Text] [Related]
14. Oral diazoxide in uncontrolled malignant hypertension. Fang P; MacDonald I; Laver M; Hua A; Kincaid-Smith P Med J Aust; 1974 Oct; 2(17):621-4. PubMed ID: 4444609 [No Abstract] [Full Text] [Related]
15. Extrapyramidal reactions in adolescents treated with high-potency antipsychotics. Chiles JA Am J Psychiatry; 1978 Feb; 135(2):239-40. PubMed ID: 23686 [No Abstract] [Full Text] [Related]
16. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities]. Bordeleau JM; Tétreault L; Elie R Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390 [No Abstract] [Full Text] [Related]
17. Temporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease. Nakashima K; Shimoda M; Kuno N; Takahashi K Mov Disord; 1994 Jan; 9(1):106-7. PubMed ID: 8139589 [No Abstract] [Full Text] [Related]
18. Side effects of depot fluphenazines. Ayd FJ Compr Psychiatry; 1974; 15(4):277-84. PubMed ID: 4607070 [No Abstract] [Full Text] [Related]
19. Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies. Dreyfuss J; Beer B; Devine DD; Roberts BF; Schreiber EC Neuropharmacology; 1972 Mar; 11(2):223-30. PubMed ID: 4623662 [No Abstract] [Full Text] [Related]
20. Drug induced extrapyramidal effects--a review. Coleman JH; Hayes PE Dis Nerv Syst; 1975 Oct; 36(10):591-3. PubMed ID: 1100334 [No Abstract] [Full Text] [Related] [Next] [New Search]